Skip to content

Validation of contact less Blood pressure monitoring device

Evaluation of Continuous Non-Invasive Blood Pressure Monitoring through Dozee

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043075
Enrollment
100
Registered
2022-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: X- New Technology

Interventions

Control Intervention1: Not Applicable: Not Applicable

Sponsors

Turtle Shell Technologies
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Weight between 40 kgs to 150 kgs 2. Have been connected to ICU monitor for blood pressure measurements using both IBP and CBP 3. They/ legal representative are able and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: Weight below 40kgs and above 150kgs 2. Currently pregnant 3. Have any condition that could interfere with the subjects ability to tolerate continuous monitoring with IBP or periodic monitoring with CBP 4. Exhibit injuries, deformities, intravenous lines, or other abnormalities that, in the opinion of the investigator, may prevent proper cuff application or functioning 5. Level of agitation or non-compliance too high to enroll in opinion of PI 6. Needs the use of equipments whose operation can interfere with Dozeeâ??s signal 7. A significant medical condition in the judgment of the investigator, which may compromise the study testing procedures

Design outcomes

Primary

MeasureTime frame
Sensitivity and Accuracy of Dozee in matching the BP values from IBP and CBPTimepoint: Continuous monitoring up to 72 hours

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactPooja Kadambi

Turtle Shell Technologies

pooja@dozee.io

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026